Clinical Trial Update: Clinical Trial to Assess Rate of Onset of Bronchodilator Action in Severe Stable Chronic Obstructive Pulmonary Disease (COPD) Patients [Phase 3]

View source ↗

Summary

This entry reports the completion of a Phase 3 clinical trial assessing the onset of bronchodilator action in patients with severe stable chronic obstructive pu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Obstructive Pulmonary Disease (COPD) | Phase 3 | Status: COMPLETED